Renal transplantation remains the definitive treatment for end-stage renal disease, significantly improving both survival and quality of life. However, urological complications continue to contribute to post-transplant morbidity. Common complications include ureteral obstruction, urinary leaks and fistulae, bladder outlet obstruction, vesicoureteral reflux (VUR), and transplant-related urolithiasis (1,2). Earlier, these conditions were managed with open surgical reconstruction, which carried considerable morbidity. Over the past few decades, advancements in endourology have enabled minimally invasive approaches to become the preferred initial strategy in selected patients (11,18).

The mean age of transplant recipients in most contemporary series is approximately 40–45 years (1). This review evaluates the evolving role of endourological techniques in managing urological complications following renal transplantation.

METHOD

A literature review was done on the use of endourologic techniques for the management of complications following Renal Transplant

DISCUSSION

URETERAL OBSTRUCTION

Ureteral obstruction, most commonly due to ureterovesical anastomotic stricture, represents one of the most frequent long-term complications after renal transplantation, with an incidence ranging from 1% to 4.5% (3,6). The underlying etiology is often multifactorial, with ureteral ischemia secondary to devascularization being the predominant cause. Additional contributors include periureteral fibrosis, lymphocele formation causing extrinsic compression, and technical errors during ureteroneocystostomy (6,8).

Diagnosis is typically initiated with ultrasonography, followed by computed tomography for better anatomical delineation (5). Functional imaging may also be used in selected cases.

Traditionally, endourological interventions such as ureteral stenting or percutaneous nephrostomy were employed primarily for temporary decompression prior to definitive open reconstruction (7). Retrograde stenting can be technically challenging due to altered anatomy, making percutaneous nephrostomy a preferred initial approach in many centers (6).

Definitive endourological management includes balloon dilatation and endoureterotomy. While balloon dilatation has modest success rates, direct vision endoureterotomy has emerged as the preferred technique due to improved efficacy and safety (17). This procedure can be performed using a cold knife, electrocautery, or Holmium:YAG laser, with reported success rates ranging between 44% and 62% (7,17). Optimal candidates include patients with early presentation, short (<1 cm) distal strictures, and partial obstruction.

URINARY LEAK AND FISTULA

Urinary leak is the most common early urological complication post-transplantation, with an incidence between 1.2% and 8.9% (10). The distal ureter is particularly vulnerable due to its tenuous blood supply, making ischemic necrosis a major contributing factor. Technical issues such as a non-watertight ureterovesical anastomosis may also play a role (10).

The role of prophylactic ureteral stenting remains debated. Some studies suggest reduced leak rates with routine stenting, while others demonstrate no statistically significant benefit (9).

Initial management focuses on urinary diversion and decompression using a Foley catheter and percutaneous nephrostomy (11). Imaging with antegrade ureteropyelography helps localize the leak. Associated urinomas should be promptly drained to prevent infection and secondary complications (11).

Definitive management has traditionally involved open surgical repair with ureteral reimplantation. However, endourological approaches have shown promising results. These involve maximal urinary diversion using nephrostomy, ureteral stenting, and bladder drainage (11,18). Serial imaging is performed to monitor healing. Once resolution is achieved, drainage devices are sequentially removed, although prolonged stenting (4–6 weeks) is recommended. Careful follow-up is essential due to the risk of subsequent stricture formation.

BLADDER OUTLET OBSTRUCTION

Bladder outlet obstruction and urinary retention are relatively uncommon following renal transplantation, with reported incidence rates around 1–2% (3). Contributing factors include benign prostatic hyperplasia, bladder neck contracture, urethral stricture, and neurogenic bladder dysfunction (3).

Prolonged pre-transplant dialysis and anuria may result in reduced bladder capacity and detrusor dysfunction, predisposing patients to postoperative voiding difficulties (2). Outlet procedures are generally deferred until after transplantation due to the increased risk of urethral complications in oliguric patients (3).

Urodynamic studies are particularly valuable in patients with diabetes mellitus or neurological disorders to assess bladder function and guide management (2).

VESICOURETERAL REFLUX

VUR is highly prevalent after renal transplantation, with reported incidence rates as high as 50–86% (2,5). This high incidence is largely attributed to surgical techniques that favor a wide, non-tunneled ureteral implantation to minimize the risk of stricture formation (5).

Although the clinical significance of VUR remains debated, high-grade reflux has been associated with recurrent urinary tract infections, urosepsis, hypertension, and potential long-term graft dysfunction (13).

Management is individualized. Patients with asymptomatic or low-grade reflux are often managed conservatively. However, those with recurrent infections or high-grade reflux require intervention (13). While open surgical reimplantation remains the gold standard, it is associated with significant morbidity.

Minimally invasive alternatives include endoscopic injection of bulking agents such as dextranomer/hyaluronic acid copolymer (Deflux) (12). Although success rates in transplant recipients are lower than in primary VUR, this approach remains a viable option in selected cases, particularly for low-grade reflux (12,18).

TRANSPLANT CALCULI

Urolithiasis in renal transplant recipients is rare, with reported incidence rates below 1% (14). Stones may originate from the donor kidney or develop de novo due to factors such as urinary stasis, VUR, metabolic abnormalities, or retained foreign material (15).

Unlike native kidneys, transplanted kidneys are denervated; therefore, patients typically do not experience classical renal colic. Presentation is often subtle, with findings such as graft dysfunction, hematuria, or urinary tract infection (14).

Ultrasonography is the initial imaging modality of choice, with non-contrast CT providing definitive diagnosis (16). Management depends on stone size, location, and impact on graft function.

Small, non-obstructive stones may be managed conservatively. In cases of obstruction or renal dysfunction, urgent decompression with nephrostomy or stenting is required (11).

Definitive treatment options include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL) (16). ESWL is least invasive but may be limited by graft location. URS allows direct visualization and fragment removal, while PCNL remains the preferred option for stones larger than 1.5 cm (16).

CONCLUSION

Urological complications following renal transplantation, although relatively uncommon, can significantly impact graft function and patient outcomes. The management paradigm has shifted from open surgical approaches to minimally invasive endourological techniques, which offer reduced morbidity and faster recovery (11,18).

Careful patient selection remains critical, as not all cases are suitable for endoscopic management. Nonetheless, with ongoing advancements in technology and technique, endourology continues to play an increasingly central role in the management of transplant-related urological complications.

REFERENCES

1. Modi P, Pal B, Modi J. Urological complications following renal transplantation: a review. Indian J Urol. 2016;32(3):190–198.
2. Alberts VP, Minnee RC, Idu MM. Urological complications after kidney transplantation: a systematic review. World J Urol. 2018;36(4):669–677.
3. Streeter EH, Little DM, Cranston DW, Morris PJ. The urological complications of renal transplantation: a series of 1535 patients. BJU Int. 2002;90(7):627–634.
   Rigg KM, Proud G, Taylor RM. Urological complications following renal transplantation. Transpl Int. 1994;7(2):120–126.
4. Breda A, Budde K, Figueiredo A, et al. European Association of Urology guidelines on renal transplantation: urological complications. Eur Urol. 2018;73(2):262–272.
5. Mangus RS, Haag BW, Stokes JB, et al. Management of ureteral complications in renal transplantation. Transplantation. 2004;77(9):1468–1472.
6. Kristo B, Phelan MW, Gritsch HA, Schulam PG. Treatment of ureteral strictures following renal transplantation. J Urol. 2003;170(1):54–57.
7. Harmon WJ, Streem SB, Novick AC. Ureteral complications following renal transplantation. J Urol. 1990;144(6):1447–1450.
8. Streeter EH, Little DM, Morris PJ. Role of ureteric stents in renal transplantation. BJU Int. 2002;89(9):879–882.
9. Benoit G, Blanchet P, Eschwege P, et al. Urinary complications in renal transplantation. Transplant Proc. 2001;33(1–2):266–267.
10. Duty BD, Conlin MJ, Fuchs GJ. Endourologic management of transplant complications. Urol Clin North Am. 2013;40(3):367–378.
11. Stenberg A, Lackgren G. Treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid. J Urol. 1995;154(2 Pt 2):800–803.
12. Pichler R, Tulchiner G, Fritz J, et al. Urinary tract infections and vesicoureteral reflux in renal transplant recipients. Transpl Infect Dis. 2017;19(2):e12667.
13. Abbott KC, Schenkman NS, Swanson SJ, et al. Hospitalized nephrolithiasis after renal transplantation. Am J Transplant. 2003;3(4):465–470.
14. Ferreira Cassini M, Cologna AJ, Ferreira Andrade M, et al. Lithiasis in renal transplant recipients: diagnosis and management. Clinics (Sao Paulo). 2012;67(6):657–662.
    Türk C, Neisius A, Petrik A, et al. EAU guidelines on urolithiasis. Eur Urol. 2022;82(1):1–94.
    Selli C, Carini M, Rizzo M, et al. Endourological management of ureteral stenosis in transplanted kidney. J Endourol. 1994;8(6):457–460.
15. Breda A, Territo A, Gausa L, et al. Endourological management of urological complications after kidney transplantation. World J Transplant. 2016;6(3):490–499.